# Avelios Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avelios-medical

- Industry: Healthcare IT
- Headquarters: Munich, Germany
- Website: www.avelios.com
- Total disclosed funding: $33M
- Investors on record: 4

## About

Avelios Medical GmbH is a healthcare technology company specializing in data-driven software solutions aimed at optimizing hospital workflows and patient interactions. Their innovative platform enhances healthcare efficiency through modular services. Founded in 2020, Avelios Medical GmbH is based in Munich, Germany, and offers a modular software platform for the digitization of healthcare workflows. The company was co-founded by Christian Albrecht, Nicolas Jakob, and Sebastian Krammer, who have backgrounds in technology and healthcare. In May 2026, Avelios Medical GmbH raised an undisclosed amount of venture funding from SAP SE and Fresenius Medical Care Ventures. Avelios Medical specializes in a modular and data-driven software platform designed for hospitals, focusing on the digitization and optimization of healthcare workflows. The core offerings include digital treatment documentation, a digital infrastructure for patient interaction, and data-driven administration processes, all facilitated through a state-of-the-art microservices architecture. The platform enables hospitals to streamline operations by automating administrative tasks, securely managing patient data, and integrating with existing healthcare systems. Key features include generating up to 2,000 structured data points automatically for each patient treatment, supporting enhanced research capabilities and business intelligence. Avelios serves a diverse client base, primarily consisting of hospitals and healthcare providers in various geographical markets across Europe, aiming to improve operational efficiency and patient care through innovative technological solutions. Avelios Medical operates primarily on a Software as a Service (SaaS) model, where healthcare institutions subscribe to its modular software solutions. Revenue is generated through these subscription services, allowing hospitals to access the digital platform tailored to their specific workflow needs. This transaction structure emphasizes long-term partnerships with clients, ensuring continuous updates and support without hidden costs. The company offers various modules that can be purchased individually or as part of a comprehensive package, enhancing flexibility for its clients. By focusing on digital treatment, administration, and infrastructure solutions, Avelios positions itself to capitalize on the increasing demand for efficient healthcare management systems. Avelios Medical’s funding from SAP and Fresenius Medical Care Ventures supports development of a modular hospital information system tailored to European healthcare requirements. The involvement of a software provider and healthcare operator enables system integration and validation in clinical settings, while positioning the company to benefit from demand for interoperable, standardized digital health infrastructure.

## Funding rounds

- Round, Oct 20, 2026 — Nvidia
- Series A, Jan 17, 2025, $31M — Hong Shan, High-Tech Gruenderfonds, Revent
- Seed, Nov 2, 2021, $2.3M — High-Tech Gruenderfonds, Revent

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A
- Revent (https://capitalatlas.ai/funds/revent) — Seed, Series A
- Hong Shan — Series A
- Nvidia
